相关实验视频

Updated: Jan 18, 2026

Modeling Brain Metastases Through Intracranial Injection and Magnetic Resonance Imaging

Modeling Brain Metastases Through Intracranial Injection and Magnetic Resonance Imaging

Published on: June 7, 2020

在质瘤中基于磁感应的成像:对瘤分类和边缘划分的洞察

Anita Ebrahimpour^1,2, Tayyebeh Ebrahimi³, Mahboubeh Masoumbeigi⁴

¹Department of Medical Physics and Biomedical Engineering, Tehran University of Medical Sciences (TUMS), Tehran, Iran.

NMR in biomedicine

|September 13, 2025

概括

基于灵敏度的MRI成像,包括R2*,SWI和QSM,通过评估铁含量和微血管结构,对分类质瘤和划分瘤边缘显示出希望. 与SWI相比,QSM提供了优越的组织组成差异化.

科学领域:

神经成像是一种神经成像.
生物物理学的生物物理.
在瘤学瘤学.

背景情况:

磁性易感是一种新兴的神经成像生物标志物,用于脑瘤.
基于敏感性的MRI技术 (R2*,SWI,QSM) 提供了对瘤生物化学和分子组成的洞察力.

研究的目的:

评估基于敏感性的MRI成像在质瘤分级中的作用.
评估这些技术在划定质瘤瘤边缘方面的有用性.

主要方法:

进行了PubMed,Scopus和谷歌学者 (2000-2025) 的结构化文献搜索.
根据包含/排除标准,选择了40项研究进行定性分析.

主要成果:

基于R2*的成像显示了通过微血管性和铁含量来分类质瘤的潜力,但其特异性较低.
在高度质瘤中,SWI更明显地检测到内瘤敏感性信号 (ITSS).
QSM提供与瘤等级相关的定量值,并将出血与化区分开来,增强诊断和治疗计划.
SWI和QSM通过突出铁沉积和微血管异常,有助于瘤边缘划分.

结论:

基于灵敏度的MRI,特别是QSM,是质瘤分级和边缘划分的强大工具,特别是当对比剂禁用时.
结合SWI,QSM,PWI或DTI的多模式方法可以提高诊断准确度.
对于QSM的常规临床采用仍然存在挑战,但人工智能集成提供了未来的潜力.

关键词:

质瘤是一种质瘤.评分评分评分评分边际的划分边际的划分量化敏感性映射量化敏感性映射 R2* 是一个R2* 类型.敏感度加权的成像成像方法

更多相关视频

Laser Capture Microdissection of Glioma Subregions for Spatial and Molecular Characterization of Intratumoral Heterogeneity, Oncostreams, and Invasion

Laser Capture Microdissection of Glioma Subregions for Spatial and Molecular Characterization of Intratumoral Heterogeneity, Oncostreams, and Invasion

Published on: April 12, 2020

Quantitative Immunohistochemistry of the Cellular Microenvironment in Patient Glioblastoma Resections

Quantitative Immunohistochemistry of the Cellular Microenvironment in Patient Glioblastoma Resections

Published on: July 31, 2017

相关概念视频

Magnetic Resonance Imaging

Magnetic Resonance Imaging

Magnetic resonance imaging (MRI) is a noninvasive medical imaging technique based on a phenomenon of nuclear physics discovered in the 1930s, in which matter exposed to magnetic fields and radio waves was found to emit radio signals. In 1970, a physician and researcher named Raymond Damadian noticed that malignant (cancerous) tissue gave off different signals than normal body tissue. He applied for a patent for the first MRI scanning device in clinical use by the early 1980s. The early MRI...